H
LIVE

Serial Number

97522434

Owner

FRED HUTCHINSON CANCER CENTER

Attorney

Tiffany Connors

First Use Date

Oct 26, 2023

Filing Date

Jul 27, 2022

Add to watchlist:

No watchlists yet
View on USPTO

H Trademark

Serial Number: 97522434 • Registration: 8042997

H is a trademark filed by FRED HUTCHINSON CANCER CENTER on July 27, 2022. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

FRED HUTCHINSON CANCER CENTER (9 trademarks)

1100 FAIRVIEW AVE. N.
SEATTLE,, WA 98109-102

Entity Type: 54

Trademark Details

Filing Date

July 27, 2022

Registration Date

November 25, 2025

First Use Anywhere

October 26, 2023

First Use in Commerce

October 26, 2023

Published for Opposition

June 6, 2023

Goods & Services

Promoting public awareness about cancer; promoting public awareness about research, prevention, diagnosis, treatment, and cure of cancer, HIV/AIDS, public health problems, and other diseases; providing a website featuring information regarding events promoting public awareness of cancer; providing a website featuring information regarding events promoting public awareness of research, prevention, diagnosis, treatment, and cure of cancer, HIV/AIDS, public health problems, and other diseases; providing medical referrals, namely, business administrative services for medical referrals; retail pharmacy services

Printed publications, namely, newsletters, pamphlets, brochures, magazines, instruction sheets, and manuals in the fields of research, prevention, detection, treatment, and cure of cancer, HIV/AIDS, other diseases, and related medical and public health problems

Consulting related to medical research in the fields of cancer and related medical conditions; medical and scientific research in the fields of cancer treatment and diagnosis; scientific research for medical purposes in the fields of cancer, infectious diseases and related medical and public health problems; medical laboratory services

Reagents and monoclonal antibodies for in vitro scientific or research use

Charitable fund raising in the area of research, prevention, detection, treatment, and cure of cancer and related medical and public health problems

Providing personal support services for patients and families of patients with cancer, namely, emotional counseling and emotional support; providing patient advocate services in the fields of prevention, diagnosis, treatment, the cure of cancer, HIV/AIDS, public health problems, and other diseases; providing a website via a global computer network featuring supportive personal stories on the subjects of health, cancer, cancer recovery and survival

Educational services, namely, developing and disseminating educational materials and programs of others to healthcare providers and patients in the fields of prevention, diagnosis, treatment, and cure of cancer, HIV/AIDS, public health problems, and other diseases; educational services, namely, providing classes, seminars, workshops, and conferences in the fields of prevention, diagnosis, treatment, and cure of cancer, HIV/AIDS, public health problems, and other diseases, and distribution of educational materials in connection therewith; providing a website featuring non-downloadable articles in the fields of prevention, diagnosis, treatment, and cure of cancer, HIV/AIDS, other diseases, and public health problems; providing on-line non-downloadable publications in the nature of newsletters, pamphlets, brochures, magazines, instruction sheets, and manuals in the fields of research, prevention, detection, treatment, and cure of cancer

Downloadable electronic publications in the nature of newsletters, pamphlets, brochures, magazines, instruction sheets, and manuals in the fields of research, prevention, detection, treatment, and cure of cancer, HIV/AIDS, other diseases, and related medical and public health problems

Medical consultations, namely, consultation services in the fields of prevention, diagnosis, treatment, and cure of cancer, HIV/AIDS, other diseases, and public health problems; medical services; medical consulting services, namely, providing medical second opinions, and prevention, diagnostic, and treatment protocols for cancer and related medical conditions; medical consulting services, namely, consulting on the treatment of cancer and other diseases, disease management, disease prevention, early detection of disease, performing standardized diagnosis of disease, staging and treatment of disease, medical care and medical care assessment, and patient care management; medical services, namely, medical counseling, diagnostic testing, and treatment services for patients with cancer and related medical conditions; medical consulting services in the area of clinical programs for bone marrow and stem cell transplants; medical services, namely, the treatment of cancer and other diseases, disease management, disease prevention, early detection of disease, performing standardized diagnosis of disease, staging and treatment of disease, medical care and medical care assessment, and counseling; medical services, namely, patient networking in the nature of providing a website via a global computer network featuring information in the fields of health, cancer treatment, cancer recovery and survival; medical and health clinic services, namely, providing clinical care for patients with cancer and related medical conditions, HIV/AIDS, and other diseases; outpatient medical services; home health care services; medical diagnosis services, namely, performing diagnosis of cancer, HIV/AIDS and related medical and public health problems; medical screening services in the field of cancer, HIV/AIDS, and related medical and public health problems; medical imaging services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; provision of health care and medical services by health care professionals via the Internet or telecommunication networks; medical services, namely, medical and psychological counseling services for patients and families of patients; health care services, namely, disease prevention in the nature of medical screenings, clinical diagnosis and wellness programs; dietary and nutritional guidance services; providing a website featuring information in the fields of prevention, diagnosis, treatment, the cure of cancer, HIV/AIDS, public health problems, and other disease

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 25, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 25, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 6, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 6, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 5, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 5, 2025 ERFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 29, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 29, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 29, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 29, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 29, 2025 COAR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 5, 2025 GNFN
FINAL REFUSAL E-MAILED
Aug 5, 2025 GNFR
SU - FINAL REFUSAL - WRITTEN
Aug 5, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 10, 2025 TEME
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 10, 2025 CHAN
ASSIGNED TO LIE
Jul 9, 2025 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 25, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 2, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 2, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 6, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 6, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jan 6, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Dec 20, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 19, 2024 AITU
USE AMENDMENT FILED
Oct 7, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 7, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 29, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jul 29, 2024 EX2G
SOU EXTENSION 2 FILED
Jul 29, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 29, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 1, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jan 30, 2024 EX1G
SOU EXTENSION 1 FILED
Jan 30, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 30, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 1, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 6, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 6, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 17, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 2, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 29, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 21, 2023 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 21, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 21, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 21, 2023 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 9, 2023 GNRN
NON-FINAL ACTION E-MAILED
Feb 9, 2023 GNRT
NON-FINAL ACTION WRITTEN
Feb 9, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 8, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 19, 2022 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2022 NWOS
NEW APPLICATION ENTERED
Jul 30, 2022 NWAP